Operating Income Summary of Abnova (Taiwan) Corporation

Abnova (Taiwan) Corporation's latest annual operating income in 2023 was 47.19 Million TWD , down -50.74% from previous year.
Abnova (Taiwan) Corporation's latest quarterly operating income in 2024 Q1 was 27.92 Million TWD , up 173.56% from previous quarter.
Abnova (Taiwan) Corporation reported an annual operating income of 95.8 Million TWD in 2022, up 153.85% from previous year.
Abnova (Taiwan) Corporation reported an annual operating income of 37.74 Million TWD in 2021, down -29.04% from previous year.
Abnova (Taiwan) Corporation reported a quarterly operating income of 27.92 Million TWD for 2024 Q1, up 173.56% from previous quarter.
Abnova (Taiwan) Corporation reported a quarterly operating income of 15.64 Million TWD for 2023 Q3, down -10.94% from previous quarter.

Annual Operating Income Chart of Abnova (Taiwan) Corporation (2023 - 2009)

Historical Annual Operating Income of Abnova (Taiwan) Corporation (2023 - 2009)

Year	Operating Income	Operating Income Growth
2023	47.19 Million TWD	-50.74%
2022	95.8 Million TWD	153.85%
2021	37.74 Million TWD	-29.04%
2020	53.18 Million TWD	86.13%
2019	28.57 Million TWD	32.11%
2018	21.63 Million TWD	-63.33%
2017	58.98 Million TWD	21.58%
2016	48.52 Million TWD	-5.0%
2015	51.07 Million TWD	-18.25%
2014	62.47 Million TWD	-21.18%
2013	79.26 Million TWD	-13.3%
2012	91.42 Million TWD	-23.98%
2011	120.25 Million TWD	-8.89%
2010	131.98 Million TWD	41.51%
2009	93.26 Million TWD	0.0%

Year	Operating Income	Operating Income Growth
2024 Q2	10.7 Million TWD	-61.67%
2024 Q1	27.92 Million TWD	173.56%
2023 Q3	15.64 Million TWD	-10.94%
2023 Q1	11.61 Million TWD	-10.04%
2023 FY	47.19 Million TWD	-50.74%
2023 Q2	17.57 Million TWD	51.27%
2023 Q4	10.2 Million TWD	-34.78%
2022 FY	95.8 Million TWD	153.85%
2022 Q2	25.4 Million TWD	14.35%
2022 Q3	35.26 Million TWD	38.79%
2022 Q4	12.91 Million TWD	-63.39%
2022 Q1	22.22 Million TWD	1410.14%
2021 Q2	14.43 Million TWD	13.46%
2021 Q1	12.72 Million TWD	-29.92%
2021 Q4	-1.69 Million TWD	-110.84%
2021 FY	37.74 Million TWD	-29.04%
2021 Q3	15.64 Million TWD	8.37%
2020 Q3	24.5 Million TWD	159.09%
2020 FY	53.18 Million TWD	86.13%
2020 Q1	9.41 Million TWD	-31.49%
2020 Q2	9.45 Million TWD	0.5%
2020 Q4	18.15 Million TWD	-25.9%
2019 Q3	10.47 Million TWD	89.45%
2019 FY	28.57 Million TWD	32.11%
2019 Q1	142 Thousand TWD	-94.41%
2019 Q4	13.73 Million TWD	31.18%
2019 Q2	5.52 Million TWD	3792.25%
2018 Q3	6.14 Million TWD	1.86%
2018 Q2	6.03 Million TWD	-12.8%
2018 FY	21.63 Million TWD	-63.33%
2018 Q4	2.54 Million TWD	-58.65%
2018 Q1	6.91 Million TWD	-38.19%
2017 Q2	12.23 Million TWD	-33.26%
2017 Q4	11.19 Million TWD	-35.07%
2017 Q1	18.33 Million TWD	41.4%
2017 FY	58.98 Million TWD	21.58%
2017 Q3	17.23 Million TWD	40.88%
2016 Q2	8.94 Million TWD	-50.37%
2016 FY	48.52 Million TWD	-5.0%
2016 Q4	12.96 Million TWD	50.75%
2016 Q3	8.59 Million TWD	-3.84%
2016 Q1	18.01 Million TWD	50.71%
2015 FY	51.07 Million TWD	-18.25%
2015 Q4	11.95 Million TWD	380.47%
2015 Q2	31.81 Million TWD	560.16%
2015 Q3	2.48 Million TWD	-92.18%
2015 Q1	4.81 Million TWD	-73.68%
2014 Q3	15.84 Million TWD	3.77%
2014 FY	62.47 Million TWD	-21.18%
2014 Q4	18.3 Million TWD	15.54%
2014 Q2	15.26 Million TWD	16.96%
2014 Q1	13.05 Million TWD	-10.21%
2013 Q3	17.06 Million TWD	-17.4%
2013 Q4	14.53 Million TWD	-14.8%
2013 FY	79.26 Million TWD	-13.3%
2013 Q1	27 Million TWD	41.54%
2013 Q2	20.66 Million TWD	-23.48%
2012 Q3	21.14 Million TWD	6.12%
2012 FY	91.42 Million TWD	-23.98%
2012 Q4	19.07 Million TWD	-9.76%
2012 Q2	19.92 Million TWD	-39.57%
2012 Q1	32.96 Million TWD	-3.36%
2011 Q3	27.51 Million TWD	-2.06%
2011 Q4	34.11 Million TWD	23.99%
2011 FY	120.25 Million TWD	-8.89%
2011 Q1	30.53 Million TWD	9.47%
2011 Q2	28.09 Million TWD	-8.01%
2010 Q1	31.67 Million TWD	0.0%
2010 FY	131.98 Million TWD	41.51%
2010 Q3	37.98 Million TWD	10.29%
2010 Q4	27.89 Million TWD	-26.55%
2010 Q2	34.43 Million TWD	8.73%
2009 FY	93.26 Million TWD	0.0%

Peer Operating Income Comparison of Abnova (Taiwan) Corporation

Name	Operating Income	Operating Income Difference
Apex Biotechnology Corp.	141.71 Million TWD	66.698%
Sinphar Pharmaceutical Co.,Ltd.	286.05 Million TWD	83.502%
Panion & Bf Biotech Inc.	156.82 Million TWD	69.907%
Chunghwa Chemical Synthesis & Biotech Co., Ltd.	280.8 Million TWD	83.194%
GenMont Biotech Incorporation	6.98 Million TWD	-575.358%
Adimmune Corporation	-722.74 Million TWD	106.53%
Tanvex BioPharma, Inc.	-2.1 Billion TWD	102.247%
Polaris Group	-1.84 Billion TWD	102.555%
Energenesis Biomedical CO.,LTD.	-261.83 Million TWD	118.024%
UnicoCell Biomed Co., Ltd.	-96.28 Million TWD	149.017%
PELL Bio-Med Technology Co. Ltd.	-411.24 Million TWD	111.476%

Global Stocks Search

Abnova (Taiwan) Corporation (4133.TW)

Operating Income Summary of Abnova (Taiwan) Corporation

Annual Operating Income Chart of Abnova (Taiwan) Corporation (2023 - 2009)

Historical Annual Operating Income of Abnova (Taiwan) Corporation (2023 - 2009)

Peer Operating Income Comparison of Abnova (Taiwan) Corporation